Found: 5
Select item for more details and to access through your institution.
Development of new predictive markers for endocrine therapy and resistance in breast cancer.
- Published in:
- Acta Oncologica, 2008, v. 47, n. 4, p. 795, doi. 10.1080/02841860802026993
- By:
- Publication type:
- Article
EU‐LIFE charter of independent life science research institutes.
- Published in:
- FEBS Letters, 2024, v. 598, n. 7, p. 719, doi. 10.1002/1873-3468.14855
- By:
- Publication type:
- Article
Breast cancer cells can switch between estrogen receptor α and ErbB signaling and combined treatment against both signaling pathways postpones development of resistance.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 121, n. 3, p. 601, doi. 10.1007/s10549-009-0506-y
- By:
- Publication type:
- Article
Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 114, n. 2, p. 263, doi. 10.1007/s10549-008-0011-8
- By:
- Publication type:
- Article
Creativity as an antidote to research becoming too predictable.
- Published in:
- EMBO Journal, 2023, v. 42, n. 4, p. 1, doi. 10.15252/embj.2022112835
- By:
- Publication type:
- Article